The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Before taking Descovy” section. Preexposure prophylaxis (PrEP) refers to taking ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
Science Africa on MSN2d
Yearly Injectable PrEP Promising in HIV PreventionBy Gift BritonThe once-a-year injectable pre-exposure prophylaxis (PrEP), Lenacapavir, has shown promising results in a recent Phase 1 clinical trial.The trial involved 40 healthy adults aged between ...
Updated evidence-based strategies aim to improve colonoscopy bowel preparation quality and patient experience and propose a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback